Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1972 4
1973 9
1974 2
1975 2
1976 1
1977 2
1978 1
1980 6
1981 14
1982 13
1983 11
1984 20
1985 19
1986 17
1987 14
1988 24
1989 16
1990 22
1991 26
1992 26
1993 18
1994 21
1995 21
1996 19
1997 25
1998 20
1999 14
2000 31
2001 20
2002 17
2003 19
2004 17
2005 13
2006 9
2007 14
2008 7
2009 11
2010 13
2011 15
2012 13
2013 11
2014 11
2015 5
2016 12
2017 17
2018 7
2019 6
2020 8
2021 6
2022 11
2023 10
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

674 results

Results by year

Filters applied: . Clear all
Page 1
MUC1-C Is a Common Driver of Acquired Osimertinib Resistance in NSCLC.
Haratake N, Ozawa H, Morimoto Y, Yamashita N, Daimon T, Bhattacharya A, Wang K, Nakashoji A, Isozaki H, Shimokawa M, Kikutake C, Suyama M, Hashinokuchi A, Takada K, Takenaka T, Yoshizumi T, Mitsudomi T, Hata AN, Kufe D. Haratake N, et al. Among authors: kufe d. J Thorac Oncol. 2024 Mar;19(3):434-450. doi: 10.1016/j.jtho.2023.10.017. Epub 2023 Nov 3. J Thorac Oncol. 2024. PMID: 37924972 Free article.
MUC1 in hematological malignancies.
Stroopinsky D, Kufe D, Avigan D. Stroopinsky D, et al. Among authors: kufe d. Leuk Lymphoma. 2016 Nov;57(11):2489-98. doi: 10.1080/10428194.2016.1195500. Epub 2016 Jun 27. Leuk Lymphoma. 2016. PMID: 27347699 Free PMC article. Review.
Single-cell analysis of localized prostate cancer patients links high Gleason score with an immunosuppressive profile.
Adorno Febles VR, Hao Y, Ahsan A, Wu J, Qian Y, Zhong H, Loeb S, Makarov DV, Lepor H, Wysock J, Taneja SS, Huang WC, Becker DJ, Balar AV, Melamed J, Deng FM, Ren Q, Kufe D, Wong KK, Adeegbe DO, Deng J, Wise DR. Adorno Febles VR, et al. Among authors: kufe d. Prostate. 2023 Jun;83(9):840-849. doi: 10.1002/pros.24524. Epub 2023 Mar 29. Prostate. 2023. PMID: 36988342
MUC1-C Dictates PBRM1-Mediated Chronic Induction of Interferon Signaling, DNA Damage Resistance, and Immunosuppression in Triple-Negative Breast Cancer.
Yamashita N, Morimoto Y, Fushimi A, Ahmad R, Bhattacharya A, Daimon T, Haratake N, Inoue Y, Ishikawa S, Yamamoto M, Hata T, Akiyoshi S, Hu Q, Liu T, Withers H, Liu S, Shapiro GI, Yoshizumi T, Long MD, Kufe D. Yamashita N, et al. Among authors: kufe d. Mol Cancer Res. 2023 Mar 1;21(3):274-289. doi: 10.1158/1541-7786.MCR-22-0772. Mol Cancer Res. 2023. PMID: 36445328 Free PMC article.
MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer.
Yasumizu Y, Rajabi H, Jin C, Hata T, Pitroda S, Long MD, Hagiwara M, Li W, Hu Q, Liu S, Yamashita N, Fushimi A, Kui L, Samur M, Yamamoto M, Zhang Y, Zhang N, Hong D, Maeda T, Kosaka T, Wong KK, Oya M, Kufe D. Yasumizu Y, et al. Among authors: kufe d. Nat Commun. 2020 Jan 17;11(1):338. doi: 10.1038/s41467-019-14219-6. Nat Commun. 2020. PMID: 31953400 Free PMC article.
674 results